Shulph Ink
Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy
Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy
YOU SAVE £4.39
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Couldn't load pickup availability
Excellent- More about Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy
Anti-angiogenic Drugs as Chemosensitizers in Cancer Therapy,Volume 19 focuses on the use of anti-angiogenic drugs as sensitizers of tumor cells to the inhibitory activity of antitumor agents, including conventional and novel anti-neoplastic agents and combination therapies. It discusses clinical applications in various types of cancer and is a valuable resource for cancer researchers, clinicians, and members of the biomedical field.
Format: Hardback
Length: 294 pages
Publication date: 28 January 2022
Publisher: Elsevier Science & Technology
Anti-angiogenic Drugs as Chemosensitizers in Cancer Therapy,Volume 19, is a comprehensive exploration of the utilization of anti-angiogenic drugs as potent sensitizers of tumor cells to the inhibitory effects of antitumor agents. The book delves into both conventional and novel anti-neoplastic agents, including cytotoxic molecules, hormones/antihormones, and immunotherapies, as well as the advancements made in combination therapies. It provides a comprehensive overview of the role of anti-angiogenic compounds, which inhibit the growth of vessels within a tumor, in conjunction with antineoplastic drugs to enhance the sensitivity of resistant tumors to their cytotoxic effects. This approach aims to reduce adverse side reactions, resistance, and improve the therapeutic response of cancer patients.
Furthermore, the book discusses clinical applications of anti-angiogenic compounds and antineoplastic drugs in various types of cancer, including colorectal, lung, breast, renal, genitourinary, skin, and brain, as well as circulating tumors. It serves as a valuable resource for cancer researchers, clinicians, and members of the biomedical field seeking to stay abreast of the latest and most promising developments in this field. By unraveling the complexities of anti-angiogenic drug therapy, this volume contributes to the understanding and development of more effective cancer treatments.
Weight: 450g
Dimension: 235 x 191 (mm)
ISBN-13: 9780323901901
This item can be found in:
UK and International shipping information
UK and International shipping information
UK Delivery and returns information:
- Delivery within 2 - 3 days when ordering in the UK.
- Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
- Returns policy: Return within 30 days of receipt for full refund.
International deliveries:
Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.
- Delivery times: within 5 - 10 days for international orders.
- Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
- Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
